Page 2 - Nasdaq Ango News Today

StockNews.com began coverage on shares of AngioDynamics (NASDAQ:ANGO – Free Report) in a report published on Thursday morning. The brokerage issued a hold rating on the medical instruments supplier’s stock. Several other research analysts have also recently issued reports on the company. Canaccord Genuity Group reduced their price objective on AngioDynamics from $20.00 to $17.00 […]

AngioDynamics, Inc. (NASDAQ:ANGO – Get Free Report) was the recipient of a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 1,850,000 shares, an increase of 51.6% from the August 31st total of 1,220,000 shares. Based on an average daily volume of 650,100 shares, the […]

AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) – Stock analysts at Zacks Research dropped their Q4 2025 earnings per share estimates for AngioDynamics in a research note issued on Tuesday, September 12th. Zacks Research analyst D. Dey now anticipates that the medical instruments supplier will post earnings per share of $0.00 for the quarter, down from […]

AngioDynamics (NASDAQ:ANGO – Get Free Report) and Carmell Therapeutics (NASDAQ:CTCX – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, earnings, profitability and institutional ownership. Analyst Recommendations This is a summary of recent […]

AngioDynamics (NASDAQ:ANGO – Get Free Report) and Carmell Therapeutics (NASDAQ:CTCX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, risk, institutional ownership and dividends. Insider and Institutional Ownership 90.5% of AngioDynamics shares […]

AngioDynamics, Inc. (NASDAQ:ANGO – Get Free Report) was the target of a significant decline in short interest in July. As of July 31st, there was short interest totalling 674,200 shares, a decline of 10.2% from the July 15th total of 751,000 shares. Currently, 1.8% of the company’s shares are short sold. Based on an average […]

Yousif Capital Management LLC lowered its position in AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) by 11.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 22,064 shares of the medical instruments supplier’s stock after selling 2,820 shares during the quarter. Yousif Capital […]

AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) – Investment analysts at Zacks Research issued their FY2026 earnings per share (EPS) estimates for shares of AngioDynamics in a report released on Wednesday, July 26th. Zacks Research analyst D. Dey forecasts that the medical instruments supplier will earn ($0.08) per share for the year. The consensus estimate for […]

StockNews.com cut shares of AngioDynamics (NASDAQ:ANGO – Free Report) from a buy rating to a hold rating in a report released on Friday morning. A number of other research firms have also commented on ANGO. Raymond James lowered shares of AngioDynamics from a strong-buy rating to an outperform rating and lowered their price target for […]

AngioDynamics, Inc. (NASDAQ:ANGO – Get Free Report) saw a significant decrease in short interest in June. As of June 30th, there was short interest totalling 727,000 shares, a decrease of 13.6% from the June 15th total of 841,000 shares. Approximately 1.9% of the shares of the stock are sold short. Based on an average daily […]